2141-V11
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for 2141-V11, covering 2025-05-06 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer [Phase 2]